This could be a compensatory response to the increase in the conventional and CD8+ T-cell populations, as the tumours of the treated animals with the highest numbers of CD4+FoxP3+ cells also exhibited the highest numbers of the conventional CD4+FoxP3− T cells and CD8+ cells. The gene discussed is CD8A; the disease is neoplasm.